TP53 and hepatocellular carcinoma: Using a MYC;p53−/− HCC mouse model, Ruiz de Galarreta et al. (94) demonstrated that β-catenin promoted immune escape by preventing the recruitment of CD103+ DCs, impairing antigen-specific T cells-mediated anti-tumor immunity.